Comment on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2025-03-01
|
| Collection: | Journal for ImmunoTherapy of Cancer |
| Accès en ligne: | https://jitc.bmj.com/content/13/3/e011845.full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|